Finasteride is of uncertain utility in treating frontal fibrosing alopecia - 18/04/17
Doi : 10.1016/j.jaad.2015.09.076
Christos Tziotzios, MA, MB BChir (Cantab), MRCP (UK), FHEA a, ⁎ 
, David A. Fenton, MBE, FRCP a, Catherine M. Stefanato, MD, FRCPath b, John A. McGrath, MD, FRCP, FMedSci a
, David A. Fenton, MBE, FRCP a, Catherine M. Stefanato, MD, FRCPath b, John A. McGrath, MD, FRCP, FMedSci a a St John's Institute of Dermatology, King's College London, Guy's Hospital, London, United Kingdom
b Department of Dermatopathology, St John's Institute of Dermatology, St Thomas' Hospital, London, United Kingdom
∗Correspondence to: Christos Tziotzios, MA, MB BChir (Cantab), MRCP (UK), FHEA, St John's Institute of Dermatology, Ninth Floor, Tower Wing, Guy's Hospital, London SE1 9RT, United KingdomSt John's Institute of DermatologyNinth Floor, Tower WingGuy's HospitalLondonSE1 9RTUnited Kingdom
Le texte complet de cet article est disponible en PDF.
| Dr Tziotzios holds a National Institute for Health Research Fellowship and an honorary contract with the National Health Service (NHS). Drs Fenton and Stefanato are employed by the NHS. Prof McGrath is employed by King's College London and holds an honorary NHS contract with the host organization (Guy's and St Thomas' Hospitals NHS Foundation Trust). |
|
| Conflicts of interest: None declared. |
© 2015
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 74 - N° 4
P. e73-e74 - avril 2016 Retour au numéro
Article précédent
- Reply: Treatment of folliculitis decalvans with photodynamic therapy
- Laura Miguel-Gómez, Sergio Vañó-Galván, Bibiana Pérez-García
- Further research needed if finasteride is to become standard of care for frontal fibrosing alopecia (FFA)
- Melissa J. Danesh, Jenny E. Murase
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?